Effect of Three Different Peak Airway Pressures on Determining Intraoperative Bleeding in Thryroidectomies

NCT03547648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2018-11-20

No results posted yet for this study

Summary

Patients undergoing thyroidectomy will be divided into three groups (30 cm H2O Group I, 40 cm H2O Group II, 50 cmH2O Group III). At the end of the operation patients will be applied peak airway pressure manually according to involved groups.The time until the first hemorrhage is seen in each group or if not seen pressure will be applied for 30 seconds and then will be ended.We will record the blood pressure, spO2, HR, the first ETCO2 after the procedure, postoperative haemorrhage that required surgery, and postoperative hematomas during peak airway pressure increase during the operation in all patients. The 1st hour blood pressure, nausea-vomiting score and pain score (NRS) will be recorded in the postoperative recovery unit.

The primary end point of the study is intraoperative bleeding detected, and the secondary end point is postoperative bleeding.

Conditions

  • Thyroid Neoplasms
  • Thyroid Nodule

Interventions

PROCEDURE

peak airway pressure

Patients' peak airway pressures will be raised to observe intraoperative bleeding in thyroidectomy surgery. Aim is to prevent postoperative bleeding.

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Murat Akcivan, resident · Istanbul University

  • Aylin Özdilek, MD · Istanbul University

  • Emre Erbabacan, Ass Prof · Istanbul University

  • Fatiş Altındaş, Prof · Istanbul University

  • Serkan Teksöz, Ass Prof · Istanbul University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2018-11-16
Completion
2018-11-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03547648 on ClinicalTrials.gov